XBiotech (XBIT) Price to FCF (2015 - 2025)

XBiotech has reported Price to FCF for 11 years, with the latest figure at 3.17 in Q4 2025.

• On a quarterly basis, Price to FCF rose 82.56% year-over-year to 3.17 in Q4 2025; TTM through Dec 2025 was 1.81, a 51.44% increase from a year earlier, with the FY2025 full-year figure at 1.81, up 51.44% from the prior year.
• Price to FCF was 3.17 for Q4 2025 at XBiotech, up from 18.56 in the prior quarter.
• The five-year high for Price to FCF was 439.25 in Q1 2021, with the low at 151.58 in Q4 2021.
• Average Price to FCF over 5 years is 15.39, with a median of 26.56 recorded in 2022.
• The sharpest annual moves came in 2021 and 2022: Price to FCF jumped 7082.63% in 2021, then sank 548.01% in 2022.
• Over 5 years, Price to FCF stood at 151.58 in 2021, then soared by 78.62% to 32.42 in 2022, then retreated by 5.86% to 34.31 in 2023, then surged by 47.02% to 18.18 in 2024, then surged by 82.56% to 3.17 in 2025.
• The last three Price to FCF figures came in at 3.17 (Q4 2025), 18.56 (Q3 2025), and 14.99 (Q2 2025), per Business Quant data.